Chelsie Xinran Li
Ch
elsie completed her MSci in Chemistry with Medicinal Chemistry at Imperial College London, graduating with first-class honours in 2024. During her undergraduate, Chelsie undertook an Undergraduate Research Opportunity Programme (UROP) during summer 2022 to work under supervision of Prof. Oscar Ces, where she investigated the impact of lipid formulations on liposome formation through vertical flow focusing method. She was also awarded a UK Turing Scheme scholarship to participate in an International Research Opportunity Programme (IROP) at Technical University of Munich, where she worked under supervision of Prof. Andreas Kremling and Dr. Katharina Flüger-grau to explore geranic acid production through Pseudomonas putida and the associated metabolic burden. Her MSci project focused on developing azobenzene-based small-molecule photoswitchable ligands targeting the sonic hedgehog pathway as antitumour agents, under supervision of Prof. Matthew Fuchter.
Chelsie has now joined the Di Antonio group as part of the ICB CDT. Her research will focus on relationship between G-quadruplexes as epigenetic regulation mediators and brain ageing and neurodegeneration. The project is co-supervised by Dr. Raffaella Nativio.